Current treatment for non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease is the most prevalent hepatopathy, estimated at 30% in the general population. In the coming years, it will likely be the most common indication for liver transplantation and the most frequent cause of hepatocellular carcinoma. Current treatment for non-alcoholic fa...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-04-01
|
| Series: | Revista de Gastroenterología de México (English Edition) |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2255534X18300628 |